M&A Deal Summary

C2Dx Acquires Hemostatix

On January 1, 2022, C2Dx acquired medical products company Hemostatix

Acquisition Highlights
  • This is C2Dx’s 2nd transaction in the Medical Products sector.
  • This is C2Dx’s 2nd transaction in the United States.
  • This is C2Dx’s 1st transaction in Tennessee.

M&A Deal Summary
Date 2022-01-01
Target Hemostatix
Sector Medical Products
Buyer(s) C2Dx
Deal Type Add-on Acquisition

Target

Hemostatix

Bartlett, Tennessee, United States
Hemostatix is a medical device company that enables precise anatomical dissection and immediate hemostasis with its surgically sharp scalpel blade. Hemostatix is based in Bartlett, Tennessee.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

C2Dx

Schoolcraft, Michigan, United States
Category Company
Founded 2019
Sector Medical Products
DESCRIPTION

C2Dx is a medical device company that invests in and refines the delivery of valuable, niche products to propel their growth and accessibility worldwide. C2Dx is committed to providing leading medical products and superior customer service while continually evolving to ensure that healthcare providers have the devices and technology they need.

DEAL STATS #
Overall 2 of 2
Sector (Medical Products) 2 of 2
Type (Add-on Acquisition) 1 of 1
State (Tennessee) 1 of 1
Country (United States) 2 of 2
Year (2022) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-02-16 Stryker - T/Pump Product

Kalamazoo, Michigan, United States

The T/Pump provides localized temperature therapy for pain relief and patient comfort. It is often used for orthopedic conditions; acute injuries, chronic pain, and muscle strains, as well as skin trauma, burns, contusions, and other localized pain diagnoses, such as arthritis and neuritis.

Buy -
Mergr

Product

Company

Legal